Gift Honors 30-Year Collaboration of Renowned Researchers
A $6.6M endowed gift by Marion Stein, MD, in memory of her late husband, Norm Letvin, MD, & in honor of Bart Haynes, MD, will significantly advance new vaccine development + therapies for HIV/A
Duke Human Vaccine Institute Wins Contract to Produce Pan-Coronavirus Vaccine
The Duke Human Vaccine Institute has received a federal contract to manufacture a pan-coronavirus vaccine candidate that can be tested in a phase 1 clinical trial.
Thomas Denny: Overseeing Duke's Vaccine Research Enterprise
As chief operating officer at the Duke Human Vaccine Institute (DHVI),
Department of Medicine Investigators at the Forefront of AIDS Research
Despite more than 40 years of research since its discovery, HIV remains a chronic disease that impacts millions of people.
Duke Human Vaccine Institute to Serve as National Coordinating Center in Fight Against Influenza, COVID-19 and Respiratory Viruses
DHVI receives $4.9 million grant from CDC to serve seven U.S. sites
On the Early Front Lines in the HIV/AIDS Fight
Since the early 1980s, Duke staff and faculty showed courage, compassion in the face of the HIV epidemic.
Duke’s Most-Cited — The Scholars Other Scientists Look To
Congratulations to Dr. Barton Haynes, director of the DHVI.
New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute has demonstrated wide protection against SARS-CoV-2 viruses and variants, including Omic
Federal Grant to Duke University School of Medicine Expands HIV Research
The Duke Human Vaccine Institute(DHVI) and the Department of Surgery at Duke University School of Medicine recei
Unraveling the Mysteries of the Immune System
In late 2019, as the world started to hear whispers of an emerging virus in China, Priyamvada Acharya, PhD, associa